We are a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine.
$14.00 - $16.00
September 13, 2019
CREDIT SUISSE SECURITIES (USA) LLC ,LEERINK SWANN & COMPANY
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Satsuma Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277